Aripiprazole, ziprasidone, and quetiapine in the treatment of first-episode nonaffective psychosis: Results of a 6-week, randomized, flexible-dose, open-label comparison

Journal of Clinical Psychopharmacology

Volumn 33, Issue 2, 2013, Pages 215-220

  Crespo Facorro, Benedicto ^a,b   Pérez Iglesias, Rocío ^b,c   Mata, Ignacio ^a,b   Ortiz Garcia De La Foz, Victor ^a   Martínez Garcia, Obdulia ^a,b   Valdizan, Elsa M ^b,d   Vazquez Barquero, José L ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

antipsychotics; clinical practice; effectiveness; efficacy; schizophrenia; treatment

Indexed keywords

ARIPIPRAZOLE; CLONAZEPAM; LITHIUM; LORMETAZEPAM; QUETIAPINE; SERTRALINE; ZIPRASIDONE;

ADOLESCENT; ADULT; AKATHISIA; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPOKINESIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; SUICIDE; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PIPERAZINES; PROSPECTIVE STUDIES; QUINOLONES; SCHIZOPHRENIA; THIAZOLES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874937199     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182825c1e     Document Type: Article

References (21)

1. Lieberman JA. Atypical antipsychotics drugs as a first-line treatment of schizophrenia: rationale and hypothesis. J Clin Psychiatry. 1996;57(suppl 11):68-71. (Pubitemid 26389788)
2. Leucht S, Komossa K, Rummel-Kluge C, et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry. 2009;166(2):152-163.
3. Crespo-Facorro B, Perez-Iglesias R, Mata I, et al. Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison. J Psychopharmacol. 2011;25(6):744-754.
4. Kahn RS, Fleischhacker WW, Boter H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008;371:1085-1097. (Pubitemid 351418005)
5. Green AI, Lieberman JA, Hamer RM, et al. Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res. 2006;86:234-243. (Pubitemid 44251272)
6. Crespo-Facorro B, Pérez-Iglesias R, Mata I, et al. Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis. Psychopharmacology (Berl). 2012;219(1):225-233.
7. Johnsen E, Jørgensen HA. Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry. 2008;8:31.
8. McEvoy JP, Lieberman JA, Perkins DO, et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry. 2007;164:1050-1060. (Pubitemid 47121394)
9. Pelayo-Terán, JM, Pérez-Iglesias, R, Raḿrez-Bonilla, M, et al. Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the PAFIP. Early Interv Psychiatry. 2008;2:178-187.
10. Sparshatt A, Taylor D, Patel MX, et al. Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine: a review. J Clin Psychiatry. 2011;72(8):1108-1123.
11. Komossa K, Rummel-Kluge C, Schmid F, et al. Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2009;(4):CD006569.
12. Tauscher-Wisniewski S, Kapur S, Tauscher J, et al. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade. J Clin Psychiatry. 2002;63(11):992-997. (Pubitemid 35388057)
13. Olfson M, Gerhard T, Huang C, et al. Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia. Schizophr Bull. 2012;38(4):845-853.
14. Glick ID, Correll CU, Altamura AC, et al. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach. J Clin Psychiatry. 2011;72(12):1616-1627.
15. Crespo-Facorro B, Perez-Iglesias R, Ramirez-Bonilla ML, et al. A practical clinical trial comparing haloperidol, risperidone and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry. 2006;67:1511-1521. (Pubitemid 44787432)
16. Lee KU, Jeon YW, Lee HK, et al. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. Hum Psychopharmacol. 2009;24(6):447-452.
17. Sajatovic M, Mullen JA, Sweitzer DE. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry. 2002;63(12):1156-1163. (Pubitemid 36084061)
18. Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162(7):1351-1360. (Pubitemid 40905587)
19. Kerwin R, Millet B, Herman E, et al. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study. Eur Psychiatry. 2007;22(7):433-443. (Pubitemid 47600616)
20. Kane JM, Barnes TR, Correll CU, et al. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short-and long-term aripiprazole trials. J Psychopharmacol. 2010;24(7):1019-1029.
21. Komossa K, Rummel-Kluge C, Schmid F, et al. Quetiapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2010;(1):CD006625.